TY - JOUR T1 - Statins used for secondary prevention in patients with stroke reduce the risk of further ischaemic strokes and cardiovascular events JF - Evidence Based Nursing JO - Evid Based Nurs SP - 24 LP - 24 DO - 10.1136/ebnurs-2019-103136 VL - 24 IS - 1 AU - James Hill AU - Marianne Hare Y1 - 2021/01/01 UR - http://ebn.bmj.com/content/24/1/24.abstract N2 - Commentary on: Tramacere, I, Boncoraglio, GB, Banzi, R, et al. Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis. BMC Med 2019;17:67. doi:10.1186/s12916-019-1298-5.The secondary use of statins is effective in reducing the absolute risk of ischaemic stroke and cardiac events in patients who previously have had an ischaemic stroke or transient ischaemic attack (TIA).Further research is required to ascertain which statin is the most effective.Stroke is one of the major causes of worldwide death and disability, with one in four people predicted to experience a stroke within their lifetime.1 After a stroke or a TIA, there remains a substantial long-term risk of recurrent stroke.2 It is recommended that statins should be used to reduce the risk of recurrent stroke with ischaemic stroke or TIA presumed … ER -